More Arovella Therapeutics Limited news
Arovella Therapeutics LimitedASX: ALA

Revenue Growth Forecasts

Mar 30, 2016 at 5:36 AM EDT · Issued by Arovella Therapeutics Limited

Filed with ASX · Mar 30, 2016 at 5:36 AM EDT

On 6ix: 6ix.com/news/revenue-growth-forecasts

View Attachment

6ix hasn’t read this filing yet.

Arovella Therapeutics Limited on 6ix

Earlier from Arovella Therapeutics

  • To commence ClipOn ProductionMar 30, 2016
  • Moves to production phase of RetralokMar 30, 2016
  • Eastland continues its global expansionMar 30, 2016
  • Eastland Associate Secures Major UK Medical DistributorMar 30, 2016
  • Commitments Test Entity - Fourth Quarter ReportMar 30, 2016

Later from Arovella Therapeutics

  • Acquisition of Cleensleeve Patents & TrademarksMar 30, 2016
  • China Market Licensing & Manufacturing AgreementMar 30, 2016
  • Expands patent coverage on PAP TechnologyMar 30, 2016
  • Half Yearly Report & AccountsMar 30, 2016
  • Market Update on Financial ResultsMar 30, 2016
All Arovella Therapeutics news releases↗

Follow Arovella Therapeutics into a list and get an email when it puts out news.

Follow Arovella Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer